DaVita falls after flagging lower revenue per treatment

Davita

05/08/2026 11:54

** Shares of DaVita DVA.N fall 4.4% to $218 premarket 
** The dialysis services provider reported late on Tuesday Q2 revenue per treatment fell to $415.87 from $417.59 a year earlier
** Reaffirmed its 2026 adjusted per-share profit expectation of $14.10 to $15.20. Analysts on average were expecting $14.82 - data compiled by LSEG 
** Q2 profit/shr of $4.02 per exceeded est. $3.88 
** As of last close, stock has doubled YTD 

 (Reporting by Siddhi Mahatole)
 ((siddhi.mahatole@thomsonreuters.com))